Should U.S. biotech companies be allowed to sell to China's police force?
On December 13, 2019, in a cavernous meeting hall in the Chinese seaside city of Xiamen, Richard Selden took the stage to show off his company’s revolutionary technology: rapid DNA testing.
Top: Richard Selden delivers a presentation on the ANDE device, December 13, 2019. Bottom: Conference attendees examine ANDE's machine. Credit: 邯郸网警
Wearing a red tie that matched the decor, Selden, the founder of ANDE, explained how the large black box can take a single sample and deliver acc
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
Chinese companies have decided that the best place to make money right now is outside of China. The phenomenon known as chu hai (出海), which translates to “go global,” has taken hold, marking a kind of second 'go out' initiative. This time, however, Chinese companies are being met with scrutiny and suspicion.
The former Commerce Secretary and ambassador to China talks about how his background shaped his approach to dealing with Beijing, the pivot to Asia and negotiating Chen Guangcheng's release.
A podcast about how the two nations, once friends, are now foes.
Hear why things are so complicated now. Host Jane Perlez, former New York Times Beijing bureau chief, talks with diplomats, spies, cultural superstars like Yo Yo Ma, and more to understand why the dangers are so high, and why relations went awry.